Literature DB >> 24203842

Cerebral vasomotor reactivity and risk of mortality: the Rotterdam Study.

Marileen L P Portegies1, Renée F A G de Bruijn, Albert Hofman, Peter J Koudstaal, M Arfan Ikram.   

Abstract

BACKGROUND AND
PURPOSE: Accumulating vascular pathology in cerebral arteries leads to impaired cerebral vasomotor reactivity. In turn, impaired cerebral vasomotor reactivity is a risk factor for stroke in clinical populations. It remains unclear whether impaired cerebral vasomotor reactivity also reflects more systemic vascular damage. We investigated whether cerebral vasomotor reactivity is associated with the risk of mortality, focusing particularly on cardiovascular mortality independent from stroke.
METHODS: Between 1997 and 1999, 1695 participants from the Rotterdam Study underwent cerebral vasomotor reactivity measurements using transcranial Doppler. Follow-up was complete until January 1, 2011. We assessed the associations between cerebral vasomotor reactivity and mortality using Cox proportional hazards models, adjusting for age, sex, and blood pressure changes and subsequently for cardiovascular risk factors. We additionally censored for incident stroke.
RESULTS: During 17 004 person-years, 557 participants died, of whom 181 due to a cardiovascular cause. In the fully adjusted model, the hazard ratio per SD decrease in vasomotor reactivity was 1.10 (95% confidence interval [CI], 1.01-1.19) for all-cause mortality, 1.09 (95% CI, 0.94-1.26) for cardiovascular mortality, and 1.10 (95% CI, 0.99-1.21) for noncardiovascular mortality. These associations remained unchanged after censoring for incident stroke.
CONCLUSIONS: We found that lower cerebral vasomotor reactivity is associated with an increased risk of death. Incident stroke does not affect this association, suggesting that a lower cerebral vasomotor reactivity reflects a generally impaired vascular system.

Entities:  

Keywords:  epidemiology; mortality; risk factors; stroke

Mesh:

Year:  2013        PMID: 24203842     DOI: 10.1161/STROKEAHA.113.002348

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  Impact of age on cerebrovascular dilation versus reactivity to hypercapnia.

Authors:  Nicole S Coverdale; Mark B Badrov; J Kevin Shoemaker
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-12       Impact factor: 6.200

2.  Clinical outcome prediction after thrombectomy of proximal middle cerebral artery occlusions by the appearance of lenticulostriate arteries on magnetic resonance angiography: A retrospective analysis.

Authors:  Johannes Kaesmacher; Kornelia Kreiser; Nathan W Manning; Alexandra S Gersing; Silke Wunderlich; Claus Zimmer; Justus F Kleine; Benedikt Wiestler; Tobias Boeckh-Behrens
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-24       Impact factor: 6.200

3.  Extra- and intracranial blood flow regulation during the cold pressor test: influence of age.

Authors:  Daniela Flück; Philip N Ainslie; Anthony R Bain; Kevin W Wildfong; Laura E Morris; James P Fisher
Journal:  J Appl Physiol (1985)       Date:  2017-06-29

Review 4.  Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection.

Authors:  Andrew M Slupe; Jeffrey R Kirsch
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-16       Impact factor: 6.200

5.  Assessment of cerebrovascular reactivity during resting state breathing and its correlation with cognitive function in hypertension.

Authors:  Ihab Hajjar; Vasilis Marmerelis; Dae C Shin; Helena Chui
Journal:  Cerebrovasc Dis       Date:  2014-08-20       Impact factor: 2.762

6.  Carbon dioxide-mediated vasomotion of extra-cranial cerebral arteries in humans: a role for prostaglandins?

Authors:  Ryan L Hoiland; Michael M Tymko; Anthony R Bain; Kevin W Wildfong; Brad Monteleone; Philip N Ainslie
Journal:  J Physiol       Date:  2016-04-06       Impact factor: 5.182

Review 7.  Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and aerobic fitness.

Authors:  Takashi Tarumi; Rong Zhang
Journal:  J Neurochem       Date:  2017-11-07       Impact factor: 5.372

8.  Cerebrovascular reactivity after cessation of menopausal hormone treatment.

Authors:  J N Barnes; R E Harvey; N A Eisenmann; K B Miller; M C Johnson; S M Kruse; B D Lahr; M J Joyner; V M Miller
Journal:  Climacteric       Date:  2019-01-21       Impact factor: 3.005

9.  Impact of mandibular advancement device therapy on cerebrovascular reactivity in patients with carotid atherosclerosis combined with OSAHS.

Authors:  Lu Qin; Na Li; Junyao Tong; Zeliang Hao; Lili Wang; Ying Zhao
Journal:  Sleep Breath       Date:  2021-01-07       Impact factor: 2.816

Review 10.  Treating the body to prevent brain injury: lessons learned from the coronavirus disease 2019 pandemic.

Authors:  Tracey H Fan; Veronika Solnicky; Sung-Min Cho
Journal:  Curr Opin Crit Care       Date:  2022-04-01       Impact factor: 3.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.